Octet® AAVX Biosensors for Rapid and Direct Quantitation of AAV Capsids

In this application note, we report the development of a rapid, high-throughput capsid assay for AV quantification on the Octet BLI platform

Viral vector vaccines offer the advantage of a rapid response to emerging pathogens or even personalized cancer treatments. Adenoviruses (AV) represent one of the most versatile and well characterized viral vectors that have been used for clinical applications up to today. However, analytical methods for the development and manufacturing of adenoviral biopharmaceuticals are still challenging and require continuous improvement to facilitate fast and reliable vector quantification and functional assessment.

The novel label-free and easy to use assay demonstrates excellent precision and reliability. The BLI method provides significant time savings compared to ELISA, qPCR or ddPCR. In addition, it is shown that crude as well as purified samples with different matrices/buffer conditions can be measured without elaborate sample preparation.

White Paper from